Alnylam Pharmaceuticals, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 71336 (Alnylam Pharmaceuticals, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
4
Package NDCs
4
Products
4
Active listings
0
Discontinued
4
Ingredients
0
Therapeutic classes
3
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 4 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| AMVUTTRA VUTRISIRAN 25 mg/.5mL INJECTION | 71336-1003-01 | — | On market | View → |
| GIVLAARI givosiran sodium 189 mg/mL INJECTION, SOLUTION | 71336-1001-01 | — | On market | View → |
| Onpattro patisiran 2 mg/mL INJECTION, LIPID COMPLEX | 71336-1000-01 | — | On market | View → |
| OXLUMO lumasiran 94.5 mg/.5mL INJECTION, SOLUTION | 71336-1002-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.